These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37536882)

  • 1. Practical Guide, Challenges, and Pitfalls in Liver Fibrosis Staging.
    Matsukuma K; Yeh MM
    Surg Pathol Clin; 2023 Sep; 16(3):457-472. PubMed ID: 37536882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver fibrosis: the good, the bad, and the patchy-an update.
    Guindi M
    Hum Pathol; 2023 Nov; 141():201-211. PubMed ID: 36702358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of fibrosis and cirrhosis in liver biopsies: an update.
    Germani G; Hytiroglou P; Fotiadu A; Burroughs AK; Dhillon AP
    Semin Liver Dis; 2011 Feb; 31(1):82-90. PubMed ID: 21344353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving strategies for liver fibrosis staging: Non-invasive assessment.
    Stasi C; Milani S
    World J Gastroenterol; 2017 Jan; 23(2):191-196. PubMed ID: 28127192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver fibrosis: histopathologic and biochemical influences on diagnostic efficacy of hepatobiliary contrast-enhanced MR imaging in staging.
    Feier D; Balassy C; Bastati N; Stift J; Badea R; Ba-Ssalamah A
    Radiology; 2013 Nov; 269(2):460-8. PubMed ID: 23878281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver biopsy in the real world-reporting, expert concordance and correlation with a pragmatic clinical diagnosis.
    Kim HP; Idowu MO; Mospan AR; Allmon AG; Roden M; Newsome P; Lok AS; Thuluvath PJ; Taunk J; Fried MW; Sanyal AJ; Barritt AS;
    Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1472-1480. PubMed ID: 34694013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging of liver disease: which option is right for my patient?
    Bhogal H; Sterling RK
    Infect Dis Clin North Am; 2012 Dec; 26(4):849-61. PubMed ID: 23083819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological evaluation of liver fibrosis and cirrhosis regression.
    Lo RC; Kim H
    Clin Mol Hepatol; 2017 Dec; 23(4):302-307. PubMed ID: 29281870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The non-invasive assessment of hepatic fibrosis.
    Gheorghe G; Bungău S; Ceobanu G; Ilie M; Bacalbaşa N; Bratu OG; Vesa CM; Găman MA; Diaconu CC
    J Formos Med Assoc; 2021 Feb; 120(2):794-803. PubMed ID: 32861550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease.
    Bedossa P; Patel K
    Gastroenterology; 2016 Jun; 150(8):1811-1822.e4. PubMed ID: 27003601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C.
    Stauber RE; Lackner C
    World J Gastroenterol; 2007 Aug; 13(32):4287-94. PubMed ID: 17708599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of Brunt's Criteria, the Non-Alcoholic Fatty Liver Disease Activity Score (NAS), and a Proposed NAS Scoring that Includes Fibrosis in Non-Alcoholic Fatty Liver Disease Staging.
    Santiago-Rolón A; Purcell D; Rosado K; Toro DH
    P R Health Sci J; 2015 Dec; 34(4):189-94. PubMed ID: 26602577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.
    Kaswala DH; Lai M; Afdhal NH
    Dig Dis Sci; 2016 May; 61(5):1356-64. PubMed ID: 27017224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of liver fibrosis: evidence and challenges.
    Sun YM; Chen SY; You H
    Chin Med J (Engl); 2020 Jul; 133(14):1696-1702. PubMed ID: 32568866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic approaches in the search for biomarkers of liver fibrosis.
    Cowan ML; Rahman TM; Krishna S
    Trends Mol Med; 2010 Apr; 16(4):171-83. PubMed ID: 20304704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathologic evaluation of liver biopsy for cirrhosis.
    Ma C; Brunt EM
    Adv Anat Pathol; 2012 Jul; 19(4):220-30. PubMed ID: 22692285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grading and staging systems for inflammation and fibrosis in chronic liver diseases.
    Goodman ZD
    J Hepatol; 2007 Oct; 47(4):598-607. PubMed ID: 17692984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver Fibrosis, Fat, and Iron Evaluation with MRI and Fibrosis and Fat Evaluation with US: A Practical Guide for Radiologists.
    Guglielmo FF; Barr RG; Yokoo T; Ferraioli G; Lee JT; Dillman JR; Horowitz JM; Jhaveri KS; Miller FH; Modi RY; Mojtahed A; Ohliger MA; Pirasteh A; Reeder SB; Shanbhogue K; Silva AC; Smith EN; Surabhi VR; Taouli B; Welle CL; Yeh BM; Venkatesh SK
    Radiographics; 2023 Jun; 43(6):e220181. PubMed ID: 37227944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive assessment of liver fibrosis: it is time for laboratory medicine.
    Sebastiani G; Gkouvatsos K; Plebani M
    Clin Chem Lab Med; 2011 Jan; 49(1):13-32. PubMed ID: 20961196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.